Viewing Study NCT00673920


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-03-05 @ 5:06 PM
Study NCT ID: NCT00673920
Status: TERMINATED
Last Update Posted: 2020-12-04
First Post: 2008-05-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
Sponsor: Genentech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RA View